FORBES J M & CO LLP - TG THERAPEUTICS INC ownership

TG THERAPEUTICS INC's ticker is TGTX and the CUSIP is 88322Q108. A total of 118 filers reported holding TG THERAPEUTICS INC in Q1 2019. The put-call ratio across all filers is 0.61 and the average weighting 0.1%.

Quarter-by-quarter ownership
FORBES J M & CO LLP ownership history of TG THERAPEUTICS INC
ValueSharesWeighting
Q2 2020$210,000
+98.1%
10,8000.0%0.04%
+54.2%
Q1 2020$106,000
-11.7%
10,8000.0%0.02%
+20.0%
Q4 2019$120,000
+96.7%
10,8000.0%0.02%
+66.7%
Q3 2019$61,000
-34.4%
10,8000.0%0.01%
-33.3%
Q2 2019$93,000
+6.9%
10,8000.0%0.02%
-5.3%
Q1 2019$87,000
+97.7%
10,8000.0%0.02%
+90.0%
Q4 2018$44,00010,8000.01%
Other shareholders
TG THERAPEUTICS INC shareholders Q1 2019
NameSharesValueWeighting ↓
Jetstream Capital LLC 200,000$7,758,0005.97%
Lion Point Capital, LP 609,128$23,628,0004.08%
RA Capital Management 3,342,743$129,665,0002.08%
Ghost Tree Capital, LLC 180,000$6,982,0001.92%
Nicholas Investment Partners, LP 660,964$25,639,0001.61%
ARDSLEY ADVISORY PARTNERS LP 350,000$13,577,0001.60%
SECTORAL ASSET MANAGEMENT INC 414,949$16,096,0001.30%
Spotlight Asset Group, Inc. 75,000$2,909,0001.12%
ACT CAPITAL MANAGEMENT, LLC 55,000$2,134,0001.10%
Pier Capital, LLC 280,486$10,880,0001.09%
View complete list of TG THERAPEUTICS INC shareholders